Safety and Efficacy of SPD489 on Executive Function Behaviors in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)
Public ClinicalTrials.gov record NCT01101022. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 4, Randomized, Double-Blind, Multicenter, Placebo-controlled, Parallel Group Study Evaluating the Safety and Efficacy of SPD489 on Executive Function (Self-Regulation) Behaviors in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD) Reporting Clinically Significant Impairment of Real-World Executive Function Behavior.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The primary objective of the study is to evaluate the efficacy of SPD489 compared to placebo on executive function (self-regulation) behaviors in adults with ADHD who report clinically significant impairment of executive function behavior in their everyday environment, as measured by the self-report Behavior Rating Inventory of Executive Function - Adult Version (BRIEF-A) Global Executive Composite (GEC) T-score.
Study identification
- NCT ID
- NCT01101022
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Enrollment
- 161 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 18 Years to 55 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 19, 2010 (Actual)
- Primary completion
- Nov 29, 2010 (Actual)
- Completion
- Nov 29, 2010 (Actual)
- Last update posted
- Jun 9, 2021
2010
United States locations
- U.S. sites
- 39
- U.S. states
- 20
- U.S. cities
- 37
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Clinical Study Centers, LLC | Little Rock | Arkansas | 72205 | — |
| Peninsula Research Assoc, Inc | Rolling Hills Estates | California | 90274 | — |
| PCSD Feighner Research | San Diego | California | 92108 | — |
| Florida Clinical Research Center, LLC | Bradenton | Florida | 34208 | — |
| Gulfcoast Clinical Research Center | Fort Myers | Florida | 33912 | — |
| Dr. George Joseph, MD and Associates PA | Jacksonville Beach | Florida | 32250 | — |
| Florida Clinical Research Center, LLC | Maitland | Florida | 32751 | — |
| CNS Healthcare | Orlando | Florida | 32806 | — |
| Janus Center For Psychiatric Research | West Palm Beach | Florida | 33407 | — |
| Atlanta Center For Medical Research | Atlanta | Georgia | 30308 | — |
| Northwest Behavioral Research Center | Marietta | Georgia | 30060 | — |
| Capstone Clinical Research | Libertyville | Illinois | 60048 | — |
| AMR-BABER Research Inc. | Naperville | Illinois | 60563 | — |
| Psychiatric Associates | Overland Park | Kansas | 66211 | — |
| Vince and Associates Clinical Research, Inc. | Overland Park | Kansas | 66211 | — |
| Four Rivers Clinical Research | Paducah | Kentucky | 42003 | — |
| Mark Hertzman MD, PC | Rockville | Maryland | 20852 | — |
| Rochester Center for Behavioral Medicine | Rochester Hills | Michigan | 48307 | — |
| The Behavioral Medicine Clinic of NW Michigan, PC | Traverse City | Michigan | 49686 | — |
| Midwest Research Group | Saint Charles | Missouri | 63301 | — |
| Center for Psychiatry and Behavioral Medicine, Inc. | Las Vegas | Nevada | 89128 | — |
| Center for Emotional Fitness | Cherry Hill | New Jersey | — | — |
| Bioscience Research, LLC | Mount Kisco | New York | 10549 | — |
| Mental Health and Addictive Disorders Research Program | New York | New York | 10016 | — |
| Triangle Neuropsychiatry | Durham | North Carolina | 27707 | — |
| Richard H. Weisler, MD, Pa & Associates | Raleigh | North Carolina | 27609 | — |
| Oregon Center for Clinical Investigations, Inc. | Portland | Oregon | 97210 | — |
| Occi, Inc (Oregon Center For Clinical Investigations, Inc.) | Salem | Oregon | 97301 | — |
| FutureSearch Trials, LP | Austin | Texas | 78756 | — |
| Bayou City Research, Ltd. | Houston | Texas | 77007 | — |
| Red Oak Psychiatry Associates P.A. | Houston | Texas | 77090 | — |
| John M. Turnbow, MD, PA | Lubbock | Texas | 79423 | — |
| Vermont Clinical Study Center | Burlington | Vermont | 05401 | — |
| Neuropsychiatric Associates | Woodstock | Vermont | 05091 | — |
| Neuroscience, Inc | Herndon | Virginia | 20170 | — |
| Eastside Therapeutic Resource | Kirkland | Washington | 98033 | — |
| Summit Research Network, LLC | Seattle | Washington | 98104 | — |
| Rockwood Clinic | Spokane | Washington | 99202 | — |
| Dean Foundation for Health, Research and Education | Middleton | Wisconsin | 53562 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01101022, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 9, 2021 · Synced Oct 27, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01101022 live on ClinicalTrials.gov.